• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    I

    Institute of Group Analysis

    院校EST. 1971
    232论文总数
    1,025引用总数

    .

    论文量&引用量时间轴

    机构学者

    论文(232)

    年份
    起
    –
    止
    排序
    1The EGATIN-TOLIP Survey 2025. A Comparison of Online and In-Person Therapy Groups in Group Analytic Training As Experienced by Trainees and Trainers
    Kristian Valbak, Linde Wotton

    Online group analytic psychotherapy has become a widespread alternative since the 2020 pandemic. Similarly, the use of online therapy in group analytic trainings has proliferated. While prominent colleagues have advocated the use of this setting in training, no research has so far been carried out. The EGATIN (European Group Analytic Training Institutions Network) TOLIP (Training OnLine and In-Person) survey 1 includes responses from 139 trainees and trainers regarding their experiences with both online and in-person personal group analysis during training. This investigation examines the significance of the physical contexts and compares the experienced benefits and preferences across the two modalities. The results are clearly in favour of in-person groups; however, online therapy groups remain a valuable, pragmatic choice.

    2026Group Analysis(2026)
    引用
    AI阅读
    加入学术空间
    2The Group Dimension Capitalism, Group Analysis, and the World Yet to Come
    Anne Aiyegbusi
    2025Psychodynamic Practice(2025)
    引用
    AI阅读
    加入学术空间
    3Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder – A Discrete Choice Experiment
    Jeff Schein,Martin Cloutier,Marjolaine Gauthier‐Loiselle,Maryaline Catillon, Yan Meng,Beatrice Libchaber, Fan Jiang,Ann Childress

    Background: Understanding patient preferences for treatments may facilitate shared decision-making. This study assessed adult patient preferences for attention-deficit/hyperactivity disorder (ADHD) treatments in a sample of 600 patients in the United States (US). Methods: A web-based discrete choice experiment (DCE) survey was conducted among treated adults with ADHD. Participants were recruited from Dynata's US panel (06/22/2023-07/06/2023). Attributes and levels, identified based on clinical inputs and published data, included efficacy and safety. Participants' preferences were estimated using conditional logistic regression. Willingness to trade-off and attributes' relative importance were calculated. Overall preferences for treatment profiles approximating centanafadine, lisdexamfetamine, atomoxetine, and viloxazine were estimated using adjusted total utilities. Results were stratified by current treatment status. Sensitivity analyses including participants who passed validity tests were conducted. Results: Among the 600 participants (mean age 37.9 years; 66.2% female; 50.8% treated), all attributes had a statistically significant impact on preferences for ADHD treatments (p < 0.001); the most important attribute was improvement in ADHD symptoms (36%), followed by risks of nausea (25%), insomnia (20%), anxiety (8%), dry mouth (6%), and feeling jittery (5%). Together, safety attributes accounted for > 60% of relative importance in decision-making. Participants were willing to forgo 0.59, 0.57, 0.49, 0.32, and 0.17 percentage points of symptom improvement to achieve one-percentage-point reduced risk of insomnia, nausea, anxiety, feeling jittery, and dry mouth, respectively. Centanafadine profile had consistently higher adjusted total utilities than its comparators. Similar results were obtained in the subgroup and sensitivity analyses. Conclusion: Efficacy was the most important attribute for patients when making treatment decision, but taken together, AEs had greater relative importance than efficacy alone. Accordingly, a profile resembling that of centanafadine would be preferred by an average patient compared to key competitors due to its favorable safety profile. These findings may help improve treatment decision-making, enhance treatment satisfaction, and foster adherence. Keywords: ADHD, decision-making, discrete choice experiment, patient-centered care, patient satisfaction, patient preference, utility

    2024Patient Preference and Adherence(2024)引用:5
    引用
    AI阅读
    加入学术空间
    4Projective Identification: a Contemporary Introduction Projective Identification: a Contemporary Introduction , Waska R, Oxford and New York, Routledge, 1st Edition, 2022, 130 Pp.,, £104 (hb), £17.59 (pb), £17.59 P. Ebook, ISBN 9780367631017.
    Michael Parker

    Click to increase image sizeClick to decrease image size Disclosure statementNo potential conflict of interest was reported by the author(s).Additional informationNotes on contributorsMichael ParkerMichael Parker is a Group Analyst and Psychodynamic Psychotherapist (Clinical) and Psychodynamic Clinical Supervisor who has worked in the NHS, the UK Prison Service and privately. He edited the book: Dynamic Security: The Democratic Therapeutic Community in Prison, (2006), London: Jessica Kingsley.

    2023Psychodynamic Practice(2023)
    引用
    AI阅读
    加入学术空间
    5Patient Preferences in Moderate-to-Severe Atopic Dermatitis (AD): A Discrete Choice Experiment (DCE)
    Steven R. Feldman,Annie Guerin,Marjolaine Gauthier-Loiselle,Ami J Claxton,Nisha C Hazra,Yan Meng,Kirsten Gallant,Sanjeev Balu
    2023SKIN The Journal of Cutaneous Medicine(2023)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 232 篇论文

    合作机构(36)

    Engie Inc.合作论文 53
    Analysis Group (United States)合作论文 3
    格拉茨工业大学合作论文 3
    New Economics Foundation合作论文 2
    Clifford Chance合作论文 2
    乌得勒支大学医学中心合作论文 2
    德勤合作论文 2
    英国政府合作论文 2
    Acceleron Pharma (United States)合作论文 2
    维克森林大学合作论文 2

    机构统计